Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: Wall Street Journal (continued)
- A.M. Vitals: FDA Cancer Division Head Defends Avastin Decision
- A.M. Vitals: FDA Clears Allergan’s Lap-Band For the Less Obese
- A.M. Vitals: FDA Extends Merck KGaA’s Cladribine Review
- A.M. Vitals: FDA Halts New Enrollment in Avandia-Actos Trial
- A.M. Vitals: FDA Inspectors Find Bacteria, Filth at Kellogg Factory
- A.M. Vitals: FDA OKs Generic Plavix
- A.M. Vitals: FDA Orders About 500 Unapproved Cold Drugs Off the Market
- A.M. Vitals: FDA Panel Endorses Seattle Genetics Lymphoma Drug
- A.M. Vitals: FDA Panel Recommends Pulling Avastin’s Breast-Cancer Approval
- A.M. Vitals: FDA Panel Unanimously Recommends Novartis MS Drug
- A.M. Vitals: FDA Panel Votes Against Diabetes Drug From Bristol, Astra
- A.M. Vitals: FDA Panel Votes to Strip Avastin’s Breast Cancer Indication
- A.M. Vitals: FDA Preparing to Ban Caffeinated Alcoholic Drinks
- A.M. Vitals: FDA Recommends Lower Doses of Zocor For Some
- A.M. Vitals: FDA Says Heavy Actos Use May Be Tied to Bladder Cancer
- A.M. Vitals: FDA Sets Phase-out of Antibiotics Use to Spur Livestock Growth
- A.M. Vitals: FDA to Bolster Painkiller Control Efforts
- A.M. Vitals: FDA to Regulate Electronic Cigarettes as Tobacco Products
- A.M. Vitals: FDA Wants More Data on Diabetes Drug from Bristol-Myers, AstraZeneca
- A.M. Vitals: FDA Warns of Fake Avastin in U.S.
- A.M. Vitals: FDA Warns On Inferior Vena Cava Filters
- A.M. Vitals: Federal Appeals Courts Set to Hear Health Law Arguments
- A.M. Vitals: Federal Medical Privacy Rules Go Back for Do-Over
- A.M. Vitals: Federal Prosecutors Want $1 Billion From Johnson & Johnson
- A.M. Vitals: Feds Won’t Try to Exclude Forest’s Solomon From Government Business
- A.M. Vitals: Figuring Out How to Handle Access to Bird-Flu Data
- A.M. Vitals: Finally! Sanofi and Genzyme Talk Takeover
- A.M. Vitals: Food Companies Cutting Calories, Cellphones and Health
- A.M. Vitals: France, Germany Halt Use of Takeda’s Actos
- A.M. Vitals: Frustrated ALS Patients Make Own Drug
- A.M. Vitals: Gene Manipulation Improves Alzheimer’s Symptoms in Mice
- A.M. Vitals: Gene Therapy Gets a Boost
- A.M. Vitals: Gene Therapy Treats Hemophilia B in Small Study
- A.M. Vitals: Genentech’s Avastin and Lucentis May Work Similarly in Eyes
- A.M. Vitals: Genetic Immunotherapy For Leukemia Holds Promise
- A.M. Vitals: Genome Mapping May Be Misleading
- A.M. Vitals: Genzyme and Sanofi Agree on Deal — In Principle
- A.M. Vitals: Genzyme Considers a Way Around Campath Impasse
- A.M. Vitals: Genzyme Factory Fixes Will Take Longer Than Thought
- A.M. Vitals: Genzyme Points to MS Drug As Sign Sanofi Bid is Too Low
- A.M. Vitals: Genzyme Rejects Takeover Offer From Sanofi-Aventis
- A.M. Vitals: Genzyme Says Sanofi Needs to Cough Up More Cash
- A.M. Vitals: Genzyme to Explore ‘Alternatives’ to Sanofi Bid
- A.M. Vitals: Genzyme, Sanofi Are Talking, But Nothing’s Guaranteed
- A.M. Vitals: Gilead Pill Cuts Risk of HIV Infection in Study
- A.M. Vitals: Gilead to Pay About $10.4 Billion For Pharmasset
- A.M. Vitals: Glaxo Takes $2.4 Billion Charge Over Lawsuits
- A.M. Vitals: Government Issues Rules on State Insurance Exchanges
- A.M. Vitals: Ground-Turkey Salmonella Outbreak Raises Antibiotics Question
- A.M. Vitals: GSK’s Hostile Human Genome Bid; Regulators Like Preventive HIV Drug
- A.M. Vitals: Gut Linked to Non-Digestive Ailments
- A.M. Vitals: HCA’s Results Show Sluggish Economy’s Effects on Hospitals
- A.M. Vitals: Health Insurers Diversify As Overhaul Trims Margins
- A.M. Vitals: Health Law Heads to Court
- A.M. Vitals: Health Law Slow to Win Favor
- A.M. Vitals: Health Law’s Insurance Waiver Program to End in September
- A.M. Vitals: Health-Care Execs Have Their Own Medicare Proposal
- A.M. Vitals: Health-Care Industry Has a Wish List for Republicans
- A.M. Vitals: Health-Care Overhaul Case Ripples Outward
- A.M. Vitals: Health-Law Debate Turns to Defining ‘Essential’ Care
- A.M. Vitals: Health-Overhaul Law Will Have ‘Moderate’ Spending Effect
- A.M. Vitals: Heart Device Wiring Problem Persists for St. Jude
- A.M. Vitals: Heart Health Report Card, Penalties for Smokers and Cheese Vs. Butter
- A.M. Vitals: HHS Will Exercise ‘Discretion’ on McDonald’s Insurance
- A.M. Vitals: Hospitals Face Consequences of Interest-Rate Bets
- A.M. Vitals: House Votes to Repeal Health Law’s Reporting Provision
- A.M. Vitals: House Votes to Repeal Health-Care Law
- A.M. Vitals: How Men and Women Sleep Differently
- A.M. Vitals: How to Treat a Kid’s Ruptured Appendix
- A.M. Vitals: Human Genome Sciences Rejects Glaxo’s $2.6 Billion Bid
- A.M. Vitals: Human Stem Cells Ease Parkinson’s Symptoms in Rodents
- A.M. Vitals: Humana Profit Up 21% On New Enrollment
- A.M. Vitals: In Louisville, Ky., Surgeons National Drivers of Spinal Fusion Surgery
- A.M. Vitals: Incoming J&J CEO says No. 1 priority is returning recalled Tylenol
- A.M. Vitals: Insurance Executives Say New Benefits Mean Higher Rates
2009 -